Hyaluronidase Market Size, Share & Trends Analysis Report By Type (Animal Derived, Synthetic), By Application (Dermatology, Chemotherapy), By Region, And Segment Forecasts, 2023 - 2030

PUBLISHED: September 13, 2023

PAGES: 130 Pages

DELIVERY TIME: 2-10 business days

SELECT AN OPTION

The global hyaluronidase market size is expected to reach USD 1,734.6 million by 2030 growing at a CAGR of 8.4% from 2023 to 2030, according to a new report by Grand View Research, Inc.. The significance of minimally invasive cosmetic procedures has increased considerably over the years and various demographic research studies have been conducted to evaluate the adoption pattern of cosmetic treatments across the globe, especially in developed countries.

Hyaluronic acid fillers form the most important component of minimally invasive aesthetic procedures carried out across the globe. Since hyaluronidase is mostly preferred while conducting these procedures, a growing number of minimally invasive aesthetic surgeries are expected to positively impact market growth. Dermal fillers have significant applications in minimally invasive facial aesthetic procedures, which has also led to an increase in the number of reported complications.

Clinicians are required to be entirely aware of the symptoms associated with hyaluronic acid injection complications in order to treat them effectively. It is crucial to establish effective protocols of action suitable for emergencies wherein the desired agents are readily available at the site of surgery or treatment. This aids in controlling the adverse impact of hyaluronic acid filler injections.

Hyaluronidase Market Report Highlights:

Animal derived hyaluronidase segment held the largest revenue share of 67.0% in 2022 and are anticipated to maintain this trend throughout the forecast period
Synthetic hyaluronidase segment is anticipated to register the fastest CAGR of 9.4% over the forecast period
The Dermatology segment held the largest revenue share of approximately 44.6% in 2022
The chemotherapy segment is estimated to register the fastest CAGR of 10.5% over the forecast period.
North America dominated the market in 2022 with the largest revenue share of 38.0% due to the high penetration of novel cosmetic treatments. In addition, dermatologists in this region are developing new non-surgical cosmetic procedures and hyaluronidase-based injectables which are among the highly recommended injectable dermal fillers
Asia Pacific is projected to witness the fastest growth owing to the numerous untapped growth opportunities in hyaluronidase-based treatments
A robust network of local manufacturers has significantly contributed to the revenue generated from this region

Product Code: GVR-4-68038-132-0

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
- 1.1.1. Type
- 1.1.2. Application
- 1.1.3. Regional scope
- 1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
- 2.2.1. Type outlook
- 2.2.2. Application outlook
- 2.2.3. Regional outlook
2.3. Competitive Insights

Chapter 3. Hyaluronidase Market Variables, Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
- 3.3.1. Market Driver Analysis
- 3.3.2. Market Restraint Analysis
3.4. Hyaluronidase Market Analysis Tools
- 3.4.1. Industry Analysis - Porter's
  - 3.4.1.1. Supplier power
  - 3.4.1.2. Buyer power
  - 3.4.1.3. Substitution threat
  - 3.4.1.4. Threat of new entrant
  - 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
  - 3.4.2.1. Political landscape
  - 3.4.2.2. Technological landscape
  - 3.4.2.3. Economic Landscape

Chapter 4. Hyaluronidase: Type Estimates & Trend Analysis

4.1. Hyaluronidase Market: Key Takeaways
4.2. Hyaluronidase Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Animal-derived hyaluronidase
- 4.3.1. Animal-derived hyaluronidase market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Synthetic hyaluronidase
- 4.4.1. Synthetic hyaluronidase market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Hyaluronidase: Application Estimates & Trend Analysis

5.1. Hyaluronidase Market: Key Takeaways
5.2. Hyaluronidase Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Dermatology
- 5.3.1. Dermatology market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Chemotherapy
- 5.4.1. Chemotherapy market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Ophthalmology
- 5.5.1. Ophthalmology market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Plastic Surgery
- 5.6.1. Plastic Surgery market estimates and forecasts, 2018 to 2030 (USD Million)
5.7. Others
- 5.7.1. Other market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Hyaluronidase Market: Regional Estimates & Trend Analysis

6.1. Regional Outlook
6.2. Hyaluronidase Market by Region: Key Takeaways
6.3. North America
- 6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.3.2. U.S.
  - 6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.3.3. Canada
  - 6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4. Europe
- 6.4.1. UK
  - 6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.2. Germany
  - 6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.3. France
  - 6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.4. Italy
  - 6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.5. Spain
  - 6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.6. Sweden
  - 6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.7. Norway
  - 6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.8. Denmark
  - 6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5. Asia Pacific
- 6.5.1. Japan
  - 6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5.2. China
  - 6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5.3. India
  - 6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5.4. Australia
  - 6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5.5. Thailand
  - 6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5.6. South Korea
  - 6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.6. Latin America
- 6.6.1. Brazil
  - 6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.6.2. Mexico
  - 6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.6.3. Argentina
  - 6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.7. MEA
- 6.7.1. Saudi Arabia
  - 6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.7.2. South Africa
  - 6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.7.3. UAE
  - 6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.7.4. Kuwait
  - 6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 7. Competitive Landscape

7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Market Participant Categorization
- 7.2.1. Amphastar Pharmaceuticals, Inc.
  - 7.2.1.1. Company overview
  - 7.2.1.2. Financial performance
  - 7.2.1.3. Product benchmarking
  - 7.2.1.4. Strategic initiatives
- 7.2.2. PrimaPharma, Inc.
  - 7.2.2.1. Company overview
  - 7.2.2.2. Financial performance
  - 7.2.2.3. Product benchmarking
  - 7.2.2.4. Strategic initiatives
- 7.2.3. Halozyme, Inc.
  - 7.2.3.1. Company overview
  - 7.2.3.2. Financial performance
  - 7.2.3.3. Product benchmarking
  - 7.2.3.4. Strategic initiatives
- 7.2.4. Bausch & Lomb Incorporated
  - 7.2.4.1. Company overview
  - 7.2.4.2. Financial performance
  - 7.2.4.3. Product benchmarking
  - 7.2.4.4. Strategic initiatives
- 7.2.5. The Cooper Companies Inc.
  - 7.2.5.1. Company overview
  - 7.2.5.2. Financial performance
  - 7.2.5.3. Product benchmarking
  - 7.2.5.4. Strategic initiatives
- 7.2.6. Sun Pharmaceutical Industries Ltd.
  - 7.2.6.1. Company overview
  - 7.2.6.2. Financial performance
  - 7.2.6.3. Product benchmarking
  - 7.2.6.4. Strategic initiatives
- 7.2.7. STEMCELL Technologies Inc.
  - 7.2.7.1. Company overview
  - 7.2.7.2. Financial performance
  - 7.2.7.3. Product benchmarking
  - 7.2.7.4. Strategic initiatives
- 7.2.8. Shreya Life Sciences Pvt. Ltd.
  - 7.2.8.1. Company overview
  - 7.2.8.2. Financial performance
  - 7.2.8.3. Product benchmarking
  - 7.2.8.4. Strategic initiatives

Product Code: GVR-4-68038-132-0

List of Tables

Table 1 List of Abbreviations
Table 2 North America hyaluronidase market, by type, 2018 - 2030 (USD Million)
Table 3 North America hyaluronidase market, by application, 2018 - 2030 (USD Million)
Table 4 North America hyaluronidase market, by region, 2018 - 2030 (USD Million)
Table 5 U.S. hyaluronidase market, by type, 2018 - 2030 (USD Million)
Table 6 U.S. hyaluronidase market, by application, 2018 - 2030 (USD Million)
Table 7 Canada hyaluronidase market, by type, 2018 - 2030 (USD Million)
Table 8 Canada hyaluronidase market, by application, 2018 - 2030 (USD Million)
Table 9 Europe hyaluronidase market, by type, 2018 - 2030 (USD Million)
Table 10 Europe hyaluronidase market, by application, 2018 - 2030 (USD Million)
Table 11 Europe hyaluronidase market, by region, 2018 - 2030 (USD Million)
Table 12 Germany hyaluronidase market, by type, 2018 - 2030 (USD Million)
Table 13 Germany hyaluronidase market, by application, 2018 - 2030 (USD Million)
Table 14 UK hyaluronidase market, by type, 2018 - 2030 (USD Million)
Table 15 UK hyaluronidase market, by application, 2018 - 2030 (USD Million)
Table 16 France hyaluronidase market, by type, 2018 - 2030 (USD Million)
Table 17 France hyaluronidase market, by application, 2018 - 2030 (USD Million)
Table 18 Italy hyaluronidase market, by type, 2018 - 2030 (USD Million)
Table 19 Italy hyaluronidase market, by application, 2018 - 2030 (USD Million)
Table 20 Spain hyaluronidase market, by type, 2018 - 2030 (USD Million)
Table 21 Spain hyaluronidase market, by application, 2018 - 2030 (USD Million)
Table 22 Sweden hyaluronidase market, by type, 2018 - 2030 (USD Million)
Table 23 Sweden hyaluronidase market, by application, 2018 - 2030 (USD Million)
Table 24 Norway hyaluronidase market, by type, 2018 - 2030 (USD Million)
Table 25 Norway hyaluronidase market, by application, 2018 - 2030 (USD Million)
Table 26 Denmark hyaluronidase market, by type, 2018 - 2030 (USD Million)
Table 27 Denmark hyaluronidase market, by application, 2018 - 2030 (USD Million)
Table 28 Asia Pacific hyaluronidase market, by type, 2018 - 2030 (USD Million)
Table 29 Asia Pacific hyaluronidase market, by application, 2018 - 2030 (USD Million)
Table 30 Asia Pacific hyaluronidase market, by region, 2018 - 2030 (USD Million)
Table 31 China hyaluronidase market, by type, 2018 - 2030 (USD Million)
Table 32 China hyaluronidase market, by application, 2018 - 2030 (USD Million)
Table 33 Japan hyaluronidase market, by type, 2018 - 2030 (USD Million)
Table 34 Japan hyaluronidase market, by application, 2018 - 2030 (USD Million)
Table 35 India hyaluronidase market, by type, 2018 - 2030 (USD Million)
Table 36 India hyaluronidase market, by application, 2018 - 2030 (USD Million)
Table 37 Australia hyaluronidase market, by type, 2018 - 2030 (USD Million)
Table 38 Australia hyaluronidase market, by application, 2018 - 2030 (USD Million)
Table 39 Thailand hyaluronidase market, by type, 2018 - 2030 (USD Million)
Table 40 Thailand hyaluronidase market, by application, 2018 - 2030 (USD Million)
Table 41 South Korea hyaluronidase market, by type, 2018 - 2030 (USD Million)
Table 42 South Korea hyaluronidase market, by application, 2018 - 2030 (USD Million)
Table 43 Latin America hyaluronidase market, by type, 2018 - 2030 (USD Million)
Table 44 Latin America hyaluronidase market, by application, 2018 - 2030 (USD Million)
Table 45 Latin America hyaluronidase market, by region, 2018 - 2030 (USD Million)
Table 46 Brazil hyaluronidase market, by type, 2018 - 2030 (USD Million)
Table 47 Brazil hyaluronidase market, by application, 2018 - 2030 (USD Million)
Table 48 Mexico hyaluronidase market, by type, 2018 - 2030 (USD Million)
Table 49 Mexico hyaluronidase market, by application, 2018 - 2030 (USD Million)
Table 50 Argentina hyaluronidase market, by type, 2018 - 2030 (USD Million)
Table 51 Argentina hyaluronidase market, by application, 2018 - 2030 (USD Million)
Table 52 Middle East and Africa hyaluronidase market, by type, 2018 - 2030 (USD Million)
Table 53 Middle East and Africa hyaluronidase market, by application, 2018 - 2030 (USD Million)
Table 54 Middle East and Africa hyaluronidase market, by region, 2018 - 2030 (USD Million)
Table 55 South Africa hyaluronidase market, by type, 2018 - 2030 (USD Million)
Table 56 South Africa hyaluronidase market, by application, 2018 - 2030 (USD Million)
Table 57 Saudi Arabia hyaluronidase market, by type, 2018 - 2030 (USD Million)
Table 58 Saudi Arabia hyaluronidase market, by application, 2018 - 2030 (USD Million)
Table 59 UAE hyaluronidase market, by type, 2018 - 2030 (USD Million)
Table 60 UAE hyaluronidase market, by application, 2018 - 2030 (USD Million)
Table 61 Kuwait hyaluronidase market, by type, 2018 - 2030 (USD Million)
Table 62 Kuwait hyaluronidase market, by application, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Hyaluronidase: Market outlook
Fig. 9 Hyaluronidase: Competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Hyaluronidase market driver impact
Fig. 15 Hyaluronidase market restraint impact
Fig. 16 Hyaluronidase market strategic initiatives analysis
Fig. 17 Hyaluronidase market: Type movement analysis
Fig. 18 Hyaluronidase market: type outlook and key takeaways
Fig. 19 Animal derived hyaluronidase market estimates and forecasts, 2018 - 2030
Fig. 20 Synthetic hyaluronidase market estimates and forecasts, 2018 - 2030
Fig. 21 Hyaluronidase market: Application movement analysis
Fig. 22 Hyaluronidase market: Application outlook and key takeaways
Fig. 23 Dermatology market estimates and forecasts, 2018 - 2030
Fig. 24 Chemotherapy market estimates and forecasts, 2018 - 2030
Fig. 25 Ophthalmology market estimates and forecasts, 2018 - 2030
Fig. 26 Plastic surgery market estimates and forecasts, 2018 - 2030
Fig. 27 Others market estimates and forecasts, 2018 - 2030
Fig. 28 Global Hyaluronidase market: Regional movement analysis
Fig. 29 Global Hyaluronidase market: Regional outlook and key takeaways
Fig. 30 North America market estimates and forecasts, 2018 - 2030
Fig. 31 U.S. market estimates and forecasts, 2018 - 2030
Fig. 32 Canada market estimates and forecasts, 2018 - 2030
Fig. 33 Europe. market estimates and forecasts, 2018 - 2030
Fig. 34 UK market estimates and forecasts, 2018 - 2030
Fig. 35 Germany market estimates and forecasts, 2018 - 2030
Fig. 36 France market estimates and forecasts, 2018 - 2030
Fig. 37 Italy market estimates and forecasts, 2018 - 2030
Fig. 38 Spain market estimates and forecasts, 2018 - 2030
Fig. 39 Sweden market estimates and forecasts, 2018 - 2030
Fig. 40 Norway market estimates and forecasts, 2018 - 2030
Fig. 41 Denmark market estimates and forecasts, 2018 - 2030
Fig. 42 Asia Pacific market estimates and forecasts, 2018 - 2030
Fig. 43 Japan market estimates and forecasts, 2018 - 2030
Fig. 44 China market estimates and forecasts, 2018 - 2030
Fig. 45 India market estimates and forecasts, 2018 - 2030
Fig. 46 Australia market estimates and forecasts, 2018 - 2030
Fig. 47 Thailand market estimates and forecasts, 2018 - 2030
Fig. 48 South Korea market estimates and forecasts, 2018 - 2030
Fig. 49 Latin America market estimates and forecasts, 2018 - 2030
Fig. 50 Brazil market estimates and forecasts, 2018 - 2030
Fig. 51 Mexico market estimates and forecasts, 2018 - 2030
Fig. 52 Argentina market estimates and forecasts, 2018 - 2030
Fig. 53 Middle East and Africa. market estimates and forecasts, 2018 - 2030
Fig. 54 Saudi Arabia market estimates and forecasts, 2018 - 2030
Fig. 55 South Africa market estimates and forecasts, 2018 - 2030
Fig. 56 UAE market estimates and forecasts, 2018 - 2030
Fig. 57 Kuwait market estimates and forecasts, 2018 - 2030